Company: PBH
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001295947-25-000039
Chunk: 16

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Item 2
Chunk 16
---
825 6.5 38,015 6.9 (4,190)(11.0)Women's Health102,234 19.5 104,804 19.1 (2,570)(2.5)Gastrointestinal90,109 17.2 86,198 15.6 3,911 4.5 Eye & Ear Care57,168 10.9 79,459 14.4 (22,291)(28.1)Dermatologicals60,644 11.6 65,243 11.8 (4,599)(7.0)Oral Care39,193 7.5 38,372 7.0 821 2.1 Other OTC5,671 1.1 5,878 1.1 (207)(3.5)Total North American OTC Healthcare443,334 84.7 472,127 85.7 (28,793)(6.1)International OTC HealthcareAnalgesics$3,175 0.6 $2,357 0.4 $818 34.7 Cough & Cold12,467 2.4 11,957 2.2 510 4.3 Women's Health10,720 2.0 10,121 1.8 599 5.9 Gastrointestinal31,875 6.0 31,878 5.8 (3)— Eye & Ear Care9,317 1.8 11,457 2.1 (2,140)(18.7)Dermatologicals5,161 1.0 3,967 0.7 1,194 30.1 Oral Care7,276 1.4 6,485 1.2 791 12.2 Other OTC319 0.1 578 0.1 (259)(44.8)Total International OTC Healthcare80,310 15.3 78,800 14.3 1,510 1.9 Total Consolidated$523,644 100.0 $550,927 100.0 $(27,283)(5.0)

Total revenues for the six months ended September 30, 2025 were $523.6 million, a decrease